TrialMolecular cancer2024

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study.

Jin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.